MovDisordV3, PascalFrancis, Curation, bibRecord, 000F17

Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation

Identifieur interne : 000F17 ( PascalFrancis/Curation ); précédent : 000F16; suivant : 000F18

Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation

Auteurs : Tatiana Witjas [France] ; Christelle Baunez [France] ; Jean Marc Henry [France] ; Marie Delfini [France] ; Jean Regis [France] ; André Ali Cherif [France] ; Jean Claude Peragut [France] ; Jean Philippe Azulay [France]

Source :

Movement disorders [ 0885-3185 ] ; 2005.

RBID : Pascal:05-0444034

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Addiction, Parkinson maladie, Dyskinésie, Substance toxicomanogène, Noyau sousthalamique, Dopamine, Stimulation cérébrale profonde.

English descriptors

KwdEn :
- Addiction, Deep brain stimulation, Dopamine, Drug of abuse, Dyskinesia, Nervous system diseases, Parkinson disease, Subthalamic nucleus.

Abstract

In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering from disabling motor fluctuations and dyskinesia associated with severe DDS. In addition to alleviating the motor disability in both patients, subthalamic nucleus (STN) deep brain stimulation greatly reduced the behavioral disorders as well as completely abolished the addiction to dopaminergic treatment. Dopaminergic addiction in patients with Parkinson's disease, therefore, does not constitute an obstacle to high-frequency STN stimulation, and this treatment may even cure the addiction.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 20`
A06				`@2 8`
A08	`01`	`1`	`ENG`	`@1 Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation`
A11	`01`	`1`		`@1 WITJAS (Tatiana)`
A11	`02`	`1`		`@1 BAUNEZ (Christelle)`
A11	`03`	`1`		`@1 HENRY (Jean Marc)`
A11	`04`	`1`		`@1 DELFINI (Marie)`
A11	`05`	`1`		`@1 REGIS (Jean)`
A11	`06`	`1`		`@1 CHERIF (André Ali)`
A11	`07`	`1`		`@1 PERAGUT (Jean Claude)`
A11	`08`	`1`		`@1 AZULAY (Jean Philippe)`
A14	`01`			`@1 Department of Neurology, University Hospital Timone @2 Marseille @3 FRA @Z 1 aut. @Z 4 aut. @Z 6 aut. @Z 8 aut.`
A14	`02`			`@1 Laboratory of Neurobiology of Cognition, CNRS @2 Marseille @3 FRA @Z 2 aut.`
A14	`03`			`@1 Department of Psychiatry, University Hospital Timone @2 Marseille @3 FRA @Z 3 aut.`
A14	`04`			`@1 Department of Functional and Stereotactic Neurosurgery, University Hospital Timone @2 Marseille @3 FRA @Z 5 aut. @Z 7 aut.`
A20				`@1 1052-1055`
A21				`@1 2005`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000132711360230`
A44				`@0 0000 @1 © 2005 INIST-CNRS. All rights reserved.`
A45				`@0 14 ref.`
A47	`01`	`1`		`@0 05-0444034`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering from disabling motor fluctuations and dyskinesia associated with severe DDS. In addition to alleviating the motor disability in both patients, subthalamic nucleus (STN) deep brain stimulation greatly reduced the behavioral disorders as well as completely abolished the addiction to dopaminergic treatment. Dopaminergic addiction in patients with Parkinson's disease, therefore, does not constitute an obstacle to high-frequency STN stimulation, and this treatment may even cure the addiction.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002B17A03`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Addiction @2 NM @5 02`
C03	`02`	`X`	`ENG`	`@0 Addiction @2 NM @5 02`
C03	`02`	`X`	`SPA`	`@0 Adicción @2 NM @5 02`
C03	`03`	`X`	`FRE`	`@0 Parkinson maladie @5 03`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease @5 03`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad @5 03`
C03	`04`	`X`	`FRE`	`@0 Dyskinésie @5 04`
C03	`04`	`X`	`ENG`	`@0 Dyskinesia @5 04`
C03	`04`	`X`	`SPA`	`@0 Disquinesia @5 04`
C03	`05`	`X`	`FRE`	`@0 Substance toxicomanogène @5 09`
C03	`05`	`X`	`ENG`	`@0 Drug of abuse @5 09`
C03	`05`	`X`	`SPA`	`@0 Sustancia toxicomanógena @5 09`
C03	`06`	`X`	`FRE`	`@0 Noyau sousthalamique @5 10`
C03	`06`	`X`	`ENG`	`@0 Subthalamic nucleus @5 10`
C03	`06`	`X`	`SPA`	`@0 Núcleo subtalámico @5 10`
C03	`07`	`X`	`FRE`	`@0 Dopamine @2 NK @2 FR @5 11`
C03	`07`	`X`	`ENG`	`@0 Dopamine @2 NK @2 FR @5 11`
C03	`07`	`X`	`SPA`	`@0 Dopamina @2 NK @2 FR @5 11`
C03	`08`	`X`	`FRE`	`@0 Stimulation cérébrale profonde @4 CD @5 96`
C03	`08`	`X`	`ENG`	`@0 Deep brain stimulation @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Système nerveux central @5 41`
C07	`05`	`X`	`ENG`	`@0 Central nervous system @5 41`
C07	`05`	`X`	`SPA`	`@0 Sistema nervioso central @5 41`
C07	`06`	`X`	`FRE`	`@0 Catécholamine @5 42`
C07	`06`	`X`	`ENG`	`@0 Catecholamine @5 42`
C07	`06`	`X`	`SPA`	`@0 Catecolamina @5 42`
C07	`07`	`X`	`FRE`	`@0 Neurotransmetteur @5 43`
C07	`07`	`X`	`ENG`	`@0 Neurotransmitter @5 43`
C07	`07`	`X`	`SPA`	`@0 Neurotransmisor @5 43`
C07	`08`	`X`	`FRE`	`@0 Mouvement involontaire @5 44`
C07	`08`	`X`	`ENG`	`@0 Involuntary movement @5 44`
C07	`08`	`X`	`SPA`	`@0 Movimiento involuntario @5 44`
C07	`09`	`X`	`FRE`	`@0 Trouble neurologique @5 45`
C07	`09`	`X`	`ENG`	`@0 Neurological disorder @5 45`
C07	`09`	`X`	`SPA`	`@0 Trastorno neurológico @5 45`
N21				`@1 311`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E04

Links to Exploration step

Pascal:05-0444034

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation</title>
<author><name sortKey="Witjas, Tatiana" sort="Witjas, Tatiana" uniqKey="Witjas T" first="Tatiana" last="Witjas">Tatiana Witjas</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Baunez, Christelle" sort="Baunez, Christelle" uniqKey="Baunez C" first="Christelle" last="Baunez">Christelle Baunez</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Laboratory of Neurobiology of Cognition, CNRS</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Henry, Jean Marc" sort="Henry, Jean Marc" uniqKey="Henry J" first="Jean Marc" last="Henry">Jean Marc Henry</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Psychiatry, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Delfini, Marie" sort="Delfini, Marie" uniqKey="Delfini M" first="Marie" last="Delfini">Marie Delfini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Regis, Jean" sort="Regis, Jean" uniqKey="Regis J" first="Jean" last="Regis">Jean Regis</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Functional and Stereotactic Neurosurgery, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Cherif, Andre Ali" sort="Cherif, Andre Ali" uniqKey="Cherif A" first="André Ali" last="Cherif">André Ali Cherif</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Peragut, Jean Claude" sort="Peragut, Jean Claude" uniqKey="Peragut J" first="Jean Claude" last="Peragut">Jean Claude Peragut</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Functional and Stereotactic Neurosurgery, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Azulay, Jean Philippe" sort="Azulay, Jean Philippe" uniqKey="Azulay J" first="Jean Philippe" last="Azulay">Jean Philippe Azulay</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0444034</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0444034 INIST</idno>
<idno type="RBID">Pascal:05-0444034</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001E04</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000F17</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation</title>
<author><name sortKey="Witjas, Tatiana" sort="Witjas, Tatiana" uniqKey="Witjas T" first="Tatiana" last="Witjas">Tatiana Witjas</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Baunez, Christelle" sort="Baunez, Christelle" uniqKey="Baunez C" first="Christelle" last="Baunez">Christelle Baunez</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Laboratory of Neurobiology of Cognition, CNRS</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Henry, Jean Marc" sort="Henry, Jean Marc" uniqKey="Henry J" first="Jean Marc" last="Henry">Jean Marc Henry</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Psychiatry, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Delfini, Marie" sort="Delfini, Marie" uniqKey="Delfini M" first="Marie" last="Delfini">Marie Delfini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Regis, Jean" sort="Regis, Jean" uniqKey="Regis J" first="Jean" last="Regis">Jean Regis</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Functional and Stereotactic Neurosurgery, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Cherif, Andre Ali" sort="Cherif, Andre Ali" uniqKey="Cherif A" first="André Ali" last="Cherif">André Ali Cherif</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Peragut, Jean Claude" sort="Peragut, Jean Claude" uniqKey="Peragut J" first="Jean Claude" last="Peragut">Jean Claude Peragut</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Functional and Stereotactic Neurosurgery, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Azulay, Jean Philippe" sort="Azulay, Jean Philippe" uniqKey="Azulay J" first="Jean Philippe" last="Azulay">Jean Philippe Azulay</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Addiction</term>
<term>Deep brain stimulation</term>
<term>Dopamine</term>
<term>Drug of abuse</term>
<term>Dyskinesia</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Subthalamic nucleus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Addiction</term>
<term>Parkinson maladie</term>
<term>Dyskinésie</term>
<term>Substance toxicomanogène</term>
<term>Noyau sousthalamique</term>
<term>Dopamine</term>
<term>Stimulation cérébrale profonde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering from disabling motor fluctuations and dyskinesia associated with severe DDS. In addition to alleviating the motor disability in both patients, subthalamic nucleus (STN) deep brain stimulation greatly reduced the behavioral disorders as well as completely abolished the addiction to dopaminergic treatment. Dopaminergic addiction in patients with Parkinson's disease, therefore, does not constitute an obstacle to high-frequency STN stimulation, and this treatment may even cure the addiction.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>20</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>WITJAS (Tatiana)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BAUNEZ (Christelle)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HENRY (Jean Marc)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>DELFINI (Marie)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>REGIS (Jean)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>CHERIF (André Ali)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>PERAGUT (Jean Claude)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>AZULAY (Jean Philippe)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Laboratory of Neurobiology of Cognition, CNRS</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Psychiatry, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Functional and Stereotactic Neurosurgery, University Hospital Timone</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>1052-1055</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000132711360230</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>14 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0444034</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering from disabling motor fluctuations and dyskinesia associated with severe DDS. In addition to alleviating the motor disability in both patients, subthalamic nucleus (STN) deep brain stimulation greatly reduced the behavioral disorders as well as completely abolished the addiction to dopaminergic treatment. Dopaminergic addiction in patients with Parkinson's disease, therefore, does not constitute an obstacle to high-frequency STN stimulation, and this treatment may even cure the addiction.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17A03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Addiction</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Addiction</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Adicción</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Dyskinésie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dyskinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Disquinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Substance toxicomanogène</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Drug of abuse</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sustancia toxicomanógena</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Noyau sousthalamique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Subthalamic nucleus</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Núcleo subtalámico</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Stimulation cérébrale profonde</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Deep brain stimulation</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Catécholamine</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Catecholamine</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Catecolamina</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Neurotransmetteur</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Neurotransmitter</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Neurotransmisor</s0>
<s5>43</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>44</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>44</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>44</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>45</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>45</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>45</s5>
</fC07>
<fN21><s1>311</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F17 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000F17 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:05-0444034
   |texte=   Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation

Addiction in Parkinson's disease : Impact of subthalamic nucleus deep brain stimulation

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri